Table 2 Comparisons of the XP C, ERCC2 and ERCC5 alleles and genotypes distributions between patients and controls
From: The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development
| Â | N (%) | Â | Â | |
|---|---|---|---|---|
Alleles and Genotypes | Controls (N = 193) | Patients (N = 193) | P value | OR (95% CI) |
XPC (rs2228001) | Â | Â | Â | Â |
   AA | 79 (40.9) | 74 (38.3) | - | 1* |
   AC | 92 (47.7) | 76 (39.4) | 0.65 | - |
   CC | 22 (11.4) | 43 (22.3) | 0.04** | 2.09 (1.09-3.99) |
   A | 250 (64.8) | 224 (58.0) | - | 1* |
   C | 136 (35.2) | 162 (42.0) | 0.06 | - |
ERCC2 (rs13181) | Â | Â | Â | Â |
   AA | 86 (44.6) | 97 (50.3) | - | 1* |
   AC | 86 (44.6) | 76 (39.4) | 0.30 | - |
   CC | 21 (10.9) | 20 (10.4) | 0.75 | - |
   A | 258 (66.8) | 270 (69.9) | - | 1* |
   C | 128 (33.2) | 116 (30.1) | 0.39 | - |
ERCC5 (rs17655) | Â | Â | Â | Â |
   GG | 87 (45.1) | 95 (49.2) | - | 1* |
   GC | 86 (44.6) | 70 (36.3) | 0.21 | - |
   CC | 20 (10.4) | 28 (14.5) | 0.55 | - |
   G | 260 (67.3) | 260 (67.3) | - | 1* |
   C | 126 (32.7) | 126 (32.7) | 0.93 | - |